-
C293529-10UCMP-Sialic acid synthetase.
-
C293529-50UCMP-Sialic acid synthetase.
-
C287795-10mgproduct description:CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1
-
C287795-25mgproduct description:CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1
-
C287795-50mgproduct description:CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1
-
C287795-5mgproduct description:CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1
-
C501142-100μgPurity ≥85% (SDS-PAGE)Product introduction1. Induced complement deficiency animal model, CVF has been used for complement deficiency model preparation in various animals (mice, rats, guinea pigs, sheep, etc.). Or it can be used to treat various
-
Ab170840-100μgCodrituzumab (anti-GPC3) is a monoclonal antibody targeting GPC3 (glypican-3). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab (anti-GPC3) induces antibody-dependent cellular cytotoxicity
-
C130754-100mgGeneral description:Coenzyme A is structurally composed of 2-aminoethanethiol, pantothenic acid and phosphorylated adenosine phosphate.Biochemical/Physiological Effects:Coenzyme A is a cofactor involved in acyl group transfer. It is essential for
-
C130754-1gGeneral description:Coenzyme A is structurally composed of 2-aminoethanethiol, pantothenic acid and phosphorylated adenosine phosphate.Biochemical/Physiological Effects:Coenzyme A is a cofactor involved in acyl group transfer. It is essential for
-
C130754-250mgGeneral description:Coenzyme A is structurally composed of 2-aminoethanethiol, pantothenic acid and phosphorylated adenosine phosphate.Biochemical/Physiological Effects:Coenzyme A is a cofactor involved in acyl group transfer. It is essential for
-
C130754-25mgGeneral description:Coenzyme A is structurally composed of 2-aminoethanethiol, pantothenic acid and phosphorylated adenosine phosphate.Biochemical/Physiological Effects:Coenzyme A is a cofactor involved in acyl group transfer. It is essential for